de Mello AH, Costa AB, Engel JDG, Rezin GT (2018) Mitochondrial dysfunction in obesity
In April 2025, OpenDoors became the first social service agency in the nation to offer access to GLP-1 drugs as part of an addiction treatment program
GLP-1 medications (glucagon-like peptide-1 receptor agonists) are prescription medicines such as semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro), and dulaglutide (Trulicity) that help control blood sugar and support weight loss
Real-world Effectiveness : Clinical trial settings may not fully reflect real-world implementation challenges, including adherence, lifestyle support, and healthcare system integration
How to Choose Quality Supplements for GLP-1 Medications Not all supplements are designed with reduced appetite, smaller meals, or changing digestion patterns in mind